for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

Novartis raises full year outlook

Posted

July 17 - Swiss drug maker Novartis raises its full year outlook as a generic competitor to its blockbuster blood pressure pill Diovan is delayed. Hayley Platt reports.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up